Cheng‐Che Chen

Papers

Total Citations

H-Index

About

Cheng‐Che Chen is a distinguished urological surgeon and researcher whose work centers on optimizing prostate cancer management, particularly through minimally invasive surgery and risk-stratified treatment strategies. His major contributions include pioneering long-term outcome analyses of robot-assisted laparoscopic radical prostatectomy (RALP) in Taiwan, with a landmark six-year study demonstrating the safety and efficacy of vesicourethral anastomosis—a critical step in preserving urinary continence post-surgery. This work, cited 7 times, has helped refine surgical techniques in Asian populations. Chen also critically evaluated active surveillance protocols for low-risk prostate cancer, showing in a 2017 study (6 citations) that a significant proportion of eligible patients harbor adverse pathological features, thereby challenging over-reliance on surveillance alone and advocating for more personalized risk assessment. His research bridges surgical innovation and evidence-based decision-making, directly impacting clinical guidelines. With a career focused on improving oncological and functional outcomes, Chen’s findings have shaped urological practice in Taiwan and beyond, earning him recognition as a key voice in the global dialogue on prostate cancer care.